[121] [122] [123] The FDA declared a shortage for Ozempic and Wegovy (but not Rybelsus) starting in August 2022
Raggi, C
The study was stratified by site of first recurrence, presence of liver metastases, disease stage, and previous nonadjuvant systemic treatment
And thats the other big concern
Whether you are exploring CJC-1295 (No DAC) 5 mg + Ipamorelin 5 mg Blend for growth hormone-related investigations, recovery-focused peptide studies, or performance-oriented research, premium sourcing remains an important consideration
And then, you know, what we're attempting to do is stack it with our own protocol where we add in MSCs, extracellular vesicles, all of these cellular goodies that are readily available at birth that have a precipitous decline as we age